Charity welcomes vaccine but stresses fight continues
National charity Meningitis UK announced today that it will be investing a further £500,000 to develop vaccines to protect against the most common forms of bacterial meningitis.
This follows the Government's announcement this afternoon that a new vaccine to protect against pneumococcal meningitis will be introduced into the UK's childhood immunisation programme later this year.
Meningitis UK's Chief Executive Steve Dayman said: "Our vision is a vaccine to eradicate meningitis altogether and the introduction of a vaccine to protect against pneumococcal meningitis is another significant step towards our goal. The reason why we are investing a further half a million pounds is because there is still no vaccine to protect against the most common form of bacterial meningitis. To enable us to keep funding their vital work we desperately need public support."



